argenx to Present at Upcoming Investor Conferences
10 Novembre 2021 - 7:00AM
November 10, 2021Breda, the
Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases and cancer, today
announced that members of management will participate in several
upcoming conferences:
- Guggenheim Healthcare Talks | Idea
Forum | 3rd Annual Neuro/Immunology Day. Fireside chat on Monday,
November 15, 2021 at 9:40 a.m. ET.
- Evercore ISI 4th Annual HealthCONx
Conference. Fireside chat on Tuesday, November 30, 2021 at 12:35
p.m. ET.
- Piper Sandler 33rd Annual
Healthcare Conference. Pre-recorded fireside chat will be made
available on November 22, 2021 at 10:00 a.m. ET.
Additional information regarding these events
will be available on the Investors section of the argenx website at
argenx.com/investors.
About argenx
argenx is a global immunology company committed
to improving the lives of people suffering from severe autoimmune
diseases and cancer. Partnering with leading academic researchers
through its Immunology Innovation Program (IIP), argenx aims to
translate immunology breakthroughs into a world-class portfolio of
novel antibody-based medicines. argenx is evaluating efgartigimod
in multiple serious autoimmune diseases. argenx is also advancing
several earlier stage experimental medicines within its therapeutic
franchises. argenx has offices in Belgium, the United States,
Japan, and Switzerland. For more information, visit www.argenx.com
and follow us on LinkedIn and Twitter.
For further information, please
contact:
Media:Kelsey
Kirkkkirk@argenx.com
Joke Comijn (EU)jcomijn@argenx.com
Investors:
Beth DelGiaccobdelgiacco@argenx.com
Michelle Greenblattmgreenblatt@argenx.com
Argen X (EU:ARGX)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Argen X (EU:ARGX)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024
